`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`SANDOZ INC.,
`APOTEX INC., APOTEX CORP.,
`EMCURE PHARMACEUTICALS LTD.,
`HERITAGE PHARMA LABS INC.,
`HERITAGE PHARMACEUTICALS INC.,
`GLENMARK PHARMACEUTICALS, INC., USA,
`GLENMARK HOLDING SA,
`GLENMARK PHARMACEUTICALS, LTD.,
`MYLAN LABORATORIES LIMITED,
`TEVA PHARMACEUTICALS USA, INC.
`and FRESENIUS KABI USA, LLC,
`
`Petitioners
`
`v .
`
`ELI LILLY AND COMPANY,
`
`Patent Owner.
`
`Case IPR2016-003181
`U.S. Patent 7,772,209
`
`
`
`
`
`
`
`
`
`
`PETITIONER SANDOZ INC.’S NOTICE OF DEPOSITION OF BRUCE A
`CHABNER, M.D.
`
`
`1 Cases IPR2016-01340 and IPR2016-01429 have been joined with the instant
`proceeding.
`
`
`
`Pursuant to 37 C.F.R. § 42.53, Petitioner Sandoz Inc. (“Sandoz”) by and
`
`through their attorneys will conduct cross-examination by deposition of Bruce A.
`
`Chabner, M.D. Dr. Chabner’s deposition will take place, as agreed by counsel for
`
`the parties, on November 10, 2016, commencing at 8:30 a.m., or such other time as
`
`may be agreed by counsel, at Foley Hoag, Seaport West, 155 Seaport Blvd, Boston,
`
`MA 02210-2600. Counsel for Patent Owner has represented that Dr. Chabner is
`
`willing to appear on the date and location indicated above.
`
`The cross-examination will be taken before a Notary Public or other officer
`
`authorized by law to administer oaths. It will be recorded using audiotape and/or
`
`stenographic means. Sandoz also intends to videotape the cross-examination of Dr.
`
`Chabner. The arrangements for the court reporter who will record the deposition
`
`using audiotape and/or stenographic means as well as the videographer will be
`
`made by counsel for Sandoz.
`
`Dated: October 27, 2016
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`/s/ Ralph J. Gabric
`Ralph J. Gabric (Reg. No. 34,167)
`Laura L. Lydigsen
`Bryan T. Richardson, Ph.D. (Reg. No.
`70,572)
`Joshua H. James (Reg. No. 72,568)
`Brinks Gilson & Lione
`NBC Tower – Suite 3600
`455 N. Cityfront Plaza Dr.
`Chicago, Illinois 60611
`
`1
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that true and correct copies of the foregoing document was
`served on October 27, 2016 via email to the following individuals at the email
`addresses below.
`
`Dov P. Grossman (Reg. No. 72,525)
`Williams & Connolly LLP
`725 Twelfth St. NW
`Washington DC 20005
`Direct Phone: 202-434-5812
`Facsimile: 202-434-5029
`dgrossman@wc.com
`
`David M. Krinsky (Reg. No. 72,339)
`Williams & Connolly LLP
`725 Twelfth St. NW
`Washington DC 20005
`Direct Phone: 202-434-5338
`Facsimile: 202-480-8302
`dkrinsky@wc.com
`
`Adam L. Perlman
`Williams & Connolly LLP
`725 Twelfth St. NW
`Washington DC 20005
`Direct Phone: 202-434-5244
`aperlman@wc.com
`
`James P. Leeds (Reg. No. 35,241)
`Eli Lilly and Company
`Lilly Corporate Center
`Indianapolis, IN 46285
`Direct Phone: 317-276-1667
`Facsimile: 317-277-6534
`leeds_james@lilly.com
`
`John C. Demeter (Reg. No. 30,167)
`Eli Lilly and Company
`
`
`
`
`
`Lilly Corporate Center
`Indianapolis, IN 46285
`Direct Phone: 317-276-3785
`Facsimile: 317-276-3861
`demeter_john_c@lilly.com
`
`
`
`
`
`/s/ Ralph J. Gabric
`Ralph J. Gabric (Reg. No. 34,167)
`Laura L. Lydigsen
`Bryan T. Richardson, Ph.D. (Reg. No.
`70,572)
`Joshua H. James (Reg. No. 72,568)
`Brinks Gilson & Lione
`NBC Tower – Suite 3600
`455 N. Cityfront Plaza Dr.
`Chicago, Illinois 60611
`
`
`
`
`
`Dated: October 27, 2016
`
`
`
`
`
`
`